CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 100 enrolled
Drug / intervention
Additional 2 weeks of CPAPother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04295564
NCT04295564N/ACompleted
CompareCT.gov

Extending CPAP Therapy in Stable Preterm Infants to Increase Lung Growth and Function: A Randomized Controlled Trial

Cynthia McEvoy·interventional·Posted Mar 4, 2020·Updated Aug 17, 2025

In Brief

A clinical study evaluating Additional 2 weeks of CPAP for Neonatal and 2 related conditions. Completed, enrolled 100 participants across 1 site.

Detailed Summary

This is a study to see if an extra 2 weeks of continuous positive airway pressure (CPAP) in stable preterm infants in the neonatal intensive care unit (NICU) can cause increased lung growth and lung function in the infants as measured at 6 months of age by pulmonary function testing.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNeonatal, Premature Birth, Respiratory Distress Syndrome
CountriesUnited States
CollaboratorsIndiana University, National Heart, Lung, and Blood Institute (NHLBI)

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedMar 4, 2020
Enrollment StartJan 10, 2020
Primary CompletionSep 18, 2023
Study CompletionMar 15, 2024
TodayJul 2, 2026
Enrollment to primary: 3.7 yearsPosted 6.3 years ago

Interventions

Additional 2 weeks of CPAPother

Subjects will be randomized to an additional 2 weeks of CPAP vs. discontinuing CPAP per usual care.